MAPT and tauopathy: Our findings indicate that despite not affecting cognitive behavior, amylin significantly exacerbated tauopathy in the visual cortex of diabetic tau transgenic mice (STZ/AMY group), as observed by immunostaining with AT8 and MC1 antibodies selective for p-tau (Fig. 4).